Novartis AG (BSP:N1VS34)
R$ 64.54 4.05 (6.7%) Market Cap: 1.29 Tn Enterprise Value: 1.39 Tn PE Ratio: 13.36 PB Ratio: 5.41 GF Score: 77/100

Novartis AG Cardiovascular Update Call Transcript

May 18, 2021 / 03:30PM GMT
Release Date Price: R$46.85
Operator

Good morning and good afternoon, and welcome to the Novartis cardiovascular update. (Operator Instructions) And the conference is being recorded today. (Operator Instructions) A recording of the conference call, including the Q&A session, will be available on our website shortly after the call ends. (Operator Instructions)

With that, I would like to hand over to Mr. Samir Shah, Head of Investor Relations. Please go ahead, sir.

Samir Shah
Novartis AG - Global Head of IR

Thank you very much, and good morning and good afternoon to everybody. A big, big thank you for joining us this afternoon in European time for the Novartis Cardiovascular Update. With us today, we have quite a lot of speakers, but hopefully, we'll leave enough time after the presentation for the questions and answers.

We have Dave Soergel, who's the Global Head of Cardiovascular, Renal and Metabolism Development; Rod Wooten, who is the Global Head of Marketing, Novartis Pharmaceutical; Victor Bulto, who's Head of Novartis Pharmaceuticals U.S.; and our external speaker is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot